首页|和厚朴酚通过Yes相关蛋白元件对胃癌小鼠铁死亡的机制

和厚朴酚通过Yes相关蛋白元件对胃癌小鼠铁死亡的机制

Mechanism of magnolol on ferroptosis in gastric cancer mice through Yes related protein elements

扫码查看
目的 观察和厚朴酚对胃癌小鼠铁死亡的影响,并探讨其机制.方法 按照区组化随机法将24只小鼠分为对照组、和厚朴酚组、铁死亡抑制组和铁死亡激动组,每组6只,建立胃癌细胞株荷瘤小鼠模型.连续给药8周后获取瘤重/体重比、肝脏指数、肾脏指数、脾脏指数;免疫组织化学染色法测定肿瘤组织增殖细胞相关抗原(Ki-67)、增殖细胞核抗原(PCNA-1)表达;酶联免疫吸附试验(ELISA)测定肿瘤组织谷胱甘肽过氧化物酶4(GPX4)、丙二醛(MDA)、超氧化物歧化酶(SOD)水平;免疫印迹法测定肿瘤组织酰基辅酶A合成酶长链4(ACSL4)、转铁蛋白受体(TFRC)、Yes相关蛋白1(YAP-1)、磷酸化-YAP1(p-YAP1)蛋白表达.组织之间的比较行配对设计或独立样本t检验,多组间的比较行单因素方差分析.结果 和厚朴酚组瘤重/体重比低于对照组(2.99±0.97比5.02±0.83,t=0.096,P<0.05),脾脏指数高于对照组(0.25±0.07 比 0.19±0.03,t=0.087,P<0.05);铁死亡抑制组瘤重/体重比高于和厚朴酚组(4.33±0.96比2.99±0.97,t=0.092,P<0.05),脾脏指数低于和厚朴酚组(0.14±0.04比0.25±0.07,t=0.073,P<0.05);铁死亡激动组瘤重/体重比低于和厚朴酚组(2.01±0.42比2.99±0.97,t=0.081,P<0.05),和厚朴酚组肿瘤组织Ki-67、PNCA-1 表达低于对照组(9.35±2.32、10.65±2.14 比 15.37±3.86、16.23±4.62,t=1.463、1.003,P<0.05);铁死亡抑制组肿瘤组织Ki-67、PNCA-1表达高于和厚朴酚组(13.81±3.78、14.01±5.26 比 6.51±3.12、7.73±1.89,t=0.163、0.520,P<0.05);铁死亡激动组肿瘤组织Ki-67、PNCA-1 表达低于和厚朴酚组(8.76±3.54、11.25±2.92 比 16.51±2.71、15.21±3.85,t=1.623、1.152,P<0.05).和厚朴酚组肿瘤组织MDA水平高于对照组[(14.76±3.57)µmol/mg比(8.72±2.08)μmol/mg,t=1.261,P<0.05],和厚朴酚组肿瘤组织GPX4、SOD水平均低于对照组[(5.15±2.34)mU/mg、(6.08±3.41)U/mg 比(11.07±1.82)mU/mg、(13.63±2.09)U/mg,t=0.893、0.765,P<0.05];铁死亡抑制组肿瘤组织MDA水平低于和厚朴酚组[(6.23±1.48)µmol/mg 比(10.65±2.14)μmol/mg,t=0.873,P<0.05],铁死亡抑制组肿瘤组织 GPX4、SOD 水平高于和厚朴酚组[(10.12±2.15)mU/mg、(12.57±1.96)U/mg 比(4.62±1.76)mU/mg、(7.05±2.09)U/mg,t=0.751、0.765,P<0.05];铁死亡激动组肿瘤组织MDA水平高于和厚朴酚组[(9.56±2.01)μmol/mg 比(4.32±1.79)µmol/mg,t=0.521,P<0.05],铁死亡激动组肿瘤组织GPX4、SOD 水平低于和厚朴酚组[(5.71±1.28)mU/mg、(7.27±1.92)U/mg 比(9.05±1.53)mU/mg、(1 1.29±1.64)U/mg,t=0.823、0.737,P<0.05].和厚朴酚组肿瘤组织 p-YAP1/YAP1 低于对照组[(10.25±2.04)μg/L 比(18.71±1.86)μg/L,t=1.536,P<0.05];铁死亡抑制组肿瘤组织 p-YAP1/YAP1 高于和厚朴酚组[(15.17±1.26)μg/L 比(6.52±2.30)μg/L,t=1.237,P<0.05],铁死亡激动组肿瘤组织p-YAP1/YAP1低于和厚朴酚组[(7.61±1.85)μg/L比(16.54±2.06)μg/L,t=1.037,P<0.05].结论 和厚朴酚可诱导胃癌小鼠发生铁死亡,具有抑癌作用,其机制可能与抑制YAP元件有关.
Objective Observation of the effect of magnolol on ferroptosis in gastric cancer mice and exploration of its mechanism.Methods A total of 24 mice were randomly divided into a control group,a magnolol group,an iron death inhibition group,and an iron death excitation group according to the block randomization method,with 6 mice in each group,to establish a gastric cancer cell line tumor bearing mouse model.Obtain tumor weight/body weight ratio,liver index,kidney index,and spleen index after continuous administration for 8 weeks;Immunohistochemical staining was used to measure the expres-sion of proliferating cell associated antigen(Ki-67)and proliferating cell nuclear antigen(PCNA-1)in tumor tissue;Enzyme linked immunosorbent assay(ELISA)was used to measure the levels of glutathione peroxidase 4(GPX4),malondialdehyde(MDA),and superoxide dismutase(SOD)in tumor tissue;Immu-noblotting was used to measure the protein expression of acyl CoA synthase long chain 4(ACSL4),trans-ferrin receptor(TFRC),Yes related protein 1(YAP-1),and Phosphorylation YAP1(p-YAP1)in tumor tissues.Results The tumor weight/body weight ratio of the Houpo phenol group was lower than that of the control group(2.99±0.97 vs.5.02±0.83,t=0.096,P<0.05),and the spleen index was higher than that of the control group(0.25±0.07 vs.0.19±0.03,t=0.087,P<0.05);The tumor weight/body weight ratio of the iron death inhibition group was higher than that of the honokiol group(4.33±0.96 vs.2.99±0.97,t=0.092,P<0.05)and the spleen index was lower than that of the honokiol group(0.14±0.04 vs.0.25±0.07,t=0.073,P<0.05);The tumor weight/body weight ratio of the iron death activation group was lower than that of the honokiol group(2.01±0.42 vs.2.99±0.97,t=0.081,P<0.05).The expression of Ki-67 and PNCA-1 in the tumor tissue of the honokiol group was lower than that of the control group(9.35±2.32,10.65±2.14 vs.15.37±3.86,16.23±4.62,t=1.463,1.003,P<0.05);The expression of Ki-67 and PNCA-1 in tumor tissues of the iron death inhibition group was higher than that of the honokiol group(13.81±3.78,14.01±5.26 vs.6.51±3.12,7.73±1.89,t=0.163,0.520,P<0.05);The expression of Ki-67 and PNCA-1 in tumor tissues of the iron death ex-citation group was lower than that of the honokiol group(8.76±3.54,11.25±2.92 vs.16.51±2.71,15.21±3.85,t=1.623,1.152,P<0.05).The MDA level in the tumor tissue of the honokiol group was higher than that of the control group[(14.76±3.57)μmol/mg vs.(8.72±2.08)µmol/mg,t=1.261,P<0.05],while the GPX4 and SOD levels in the tumor tissue of the honokiol group were lower than those of the control group[(5.15±2.34)mU/mg,(6.08±3.41)U/mg vs.(11.07±1.82)mU/mg,(13.63±2.09)U/mg,t=0.893,0.765,P<0.05];The MDA level in the tumor tissue of the iron death inhibition group was lower than that of the honokiol group[(6.23±1.48)μmol/mg vs.(10.65±2.14)μmol/mg,t=0.873,P<0.05].The GPX4 and SOD levels in the tumor tissue of the iron death inhibition group were higher than those of the honokiol group[(10.12±2.15)mU/mg,(12.57±1.96)U/mg vs.(4.62±1.76)mU/mg,(7.05±2.09)U/mg,t=0.751,0.765,P<0.05];The MDA level in the tumor tissue of the iron death activation group was higher than that of the honokiol group[(9.56±2.01)μmol/mg vs.(4.32±1.79)μmol/mg,t=0.521,P<0.05].The GPX4 and SOD lev-els in the tumor tissue of the iron death activation group were lower than those of the honokiol group[(5.71±1.28)mU/mg,(7.27±1.92)U/mg vs.(9.05±1.53)mU/mg,(11.29±1.64)U/mg,t=0.823,0.737,P<0.05].The p-YAP1/YAP1 ratio in the Houpo phenol group was lower than that in the control group[(10.25±2.04)μg/L vs.(18.71±1.86)μg/L,t=1.536,P<0.05];The p-YAP1/YAP1 ratio in the iron death inhibition group was higher than that in the honokiol group[(15.17±1.26)µg/L vs.(6.52±2.30)µg/L,t=1.237,P<0.05],while the p-YAP1/YAP1 ratio in the iron death activation group was lower than that in the honokiol group[(7.61±1.85)µg/L vs.(16.54±2.06)µg/L,t=1.037,P<0.05].Conclusion Houpo phenol can induce ferroptosis in gastric cancer mice and has anti-cancer effects,which may be related to the inhibition of YAP elements.

HonokiolGastric cancerFerroptosisYes-associated protein 1

沈燕、张英杰、何春华

展开 >

浙江新安国际医院外科,嘉兴 314000

嘉兴大学附属第二医院胃肠外科,嘉兴 314000

和厚朴酚 胃癌 铁死亡 Yes相关蛋白1

2024

中华实验外科杂志
中华医学会

中华实验外科杂志

CSTPCD
影响因子:0.759
ISSN:1001-9030
年,卷(期):2024.41(11)